Literature DB >> 5119198

Large-scale purification of rubella virus and preparation of an experimental split rubella virus vaccine.

P Väänänen, A Vaheri.   

Abstract

Large-scale purification of rubella virus from tissue culture fluid and preparation of an experimental rubella subunit vaccine are described. The virus, purified isopycnically in sucrose gradients, was Tween 80-ether treated, and the product was filtered sterile. The vaccines were of two types, formalinized and nonformalinized. They were not infectious, had only a slight pyrogenicity, and caused no harmful symptoms in animals. The immune response in guinea pigs was better when the nonformalinized vaccine was used and the dosage was 2,500 hemagglutinating units per injection (0.5 ml).

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5119198      PMCID: PMC376293          DOI: 10.1128/am.22.3.255-259.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  26 in total

1.  Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells.

Authors:  P E Halonen; J A Stewart; A D Hall
Journal:  Ann Med Exp Biol Fenn       Date:  1967

2.  Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.

Authors:  H M Meyer; P D Parkman; T E Hobbins; F A Ennis
Journal:  Am J Dis Child       Date:  1968-06

3.  Haemagglutinin of rubella virus.

Authors:  T Furukawa; S Plotkin; D Sedwick; M Profeta
Journal:  Nature       Date:  1967-07-08       Impact factor: 49.962

4.  Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines.

Authors:  V A Fulginiti; J H Arthur; D S Pearlman; C H Kempe
Journal:  Am J Dis Child       Date:  1968-06

5.  Transmission of attenuated rubella vaccines to the human fetus. A preliminary report.

Authors:  A Vaheri; T Vesikari; N Oker-Blom; M Seppala; J Veronelli; F C Robbins; P D Parkman
Journal:  Am J Dis Child       Date:  1969-08

6.  [Properties of rubella virus hemagglutinin treated with Tween 80 and ethyl ether].

Authors:  R Laufs; R Thomssen
Journal:  Arch Gesamte Virusforsch       Date:  1968

7.  Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.

Authors:  M R Hilleman; E B Buynak; J E Whitman; R W Weibel; J Stokes
Journal:  Am J Dis Child       Date:  1969-08

8.  Improved continuous flow centrifugation with banding.

Authors:  G B Cline; C E Nunley; N G Anderson
Journal:  Nature       Date:  1966-10-29       Impact factor: 49.962

9.  Continuous-flow centrifugation combined with isopycnic banding: rotors B-8 and B-IX.

Authors:  N G Anderson; H P Barringer; J W Amburgey; G B Cline; C E Nunley; A S Berman
Journal:  Natl Cancer Inst Monogr       Date:  1966-06

10.  Density gradient centrifugation of rubella virus.

Authors:  R M McCombs; W E Rawls
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

View more
  5 in total

1.  Efficacy and immune response to rubella subunits vaccines.

Authors:  R Cappel; F De Cuyper
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

2.  Morphology, biochemical analysis and neuraminidase activity of rubella virus.

Authors:  G Bardeletti; N Kessler; M Aymard-Henry
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

3.  Structural proteins and subunits of rubella virus.

Authors:  A Vaheri; T Hovi
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

4.  Recent rubella virus infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; I Seppälä
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

5.  Characterisation of rubella virus hemagglutinin rosettes.

Authors:  M Trudel; F Marchessault; P Payment
Journal:  J Virol Methods       Date:  1981-03       Impact factor: 2.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.